These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7958544)

  • 1. Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM.
    Torlone E; Fanelli C; Rambotti AM; Kassi G; Modarelli F; Di Vincenzo A; Epifano L; Ciofetta M; Pampanelli S; Brunetti P
    Diabetologia; 1994 Jul; 37(7):713-20. PubMed ID: 7958544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
    Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
    Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM.
    Torlone E; Pampanelli S; Lalli C; Del Sindaco P; Di Vincenzo A; Rambotti AM; Modarelli F; Epifano L; Kassi G; Perriello G; Brunetti P; Bolli G
    Diabetes Care; 1996 Sep; 19(9):945-52. PubMed ID: 8875087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
    Heinemann L; Heise T; Wahl LC; Trautmann ME; Ampudia J; Starke AA; Berger M
    Diabet Med; 1996 Jul; 13(7):625-9. PubMed ID: 8840095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of insulin on the counterregulatory response to equivalent hypoglycemia in patients with insulin-dependent diabetes mellitus.
    Davis SN; Goldstein RE; Price L; Jacobs J; Cherrington AD
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1300-7. PubMed ID: 8077324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin.
    Howey DC; Bowsher RR; Brunelle RL; Woodworth JR
    Diabetes; 1994 Mar; 43(3):396-402. PubMed ID: 8314011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recent, short-term hyperglycemia on responses to hypoglycemia in humans. Relevance to the pathogenesis of hypoglycemia unawareness and hyperglycemia-induced insulin resistance.
    Fanelli C; Pampanelli S; Calderone S; Lepore M; Annibale B; Compagnucci P; Brunetti P; Bolli GB
    Diabetes; 1995 May; 44(5):513-9. PubMed ID: 7729608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin and beta-endorphin responses to hypoglycemia are reduced in well-controlled insulin-dependent diabetes mellitus.
    Kinsley BT; Levy CJ; Simonson DC
    Metabolism; 1996 Nov; 45(11):1434-40. PubMed ID: 8931651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes.
    Kishore P; Gabriely I; Cui MH; Di Vito J; Gajavelli S; Hwang JH; Shamoon H
    Diabetes; 2006 Mar; 55(3):659-66. PubMed ID: 16505228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
    Bruttomesso D; Pianta A; Mari A; Valerio A; Marescotti MC; Avogaro A; Tiengo A; Del Prato S
    Diabetes; 1999 Jan; 48(1):99-105. PubMed ID: 9892228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
    Fanelli C; Pampanelli S; Epifano L; Rambotti AM; Ciofetta M; Modarelli F; Di Vincenzo A; Annibale B; Lepore M; Lalli C
    Diabetologia; 1994 Aug; 37(8):797-807. PubMed ID: 7988782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin.
    McCrimmon RJ; Frier BM
    Diabet Med; 1997 Nov; 14(11):929-36. PubMed ID: 9400916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans.
    Fanelli C; Di Vincenzo A; Modarelli F; Lepore M; Ciofetta M; Epifano L; Pampanelli S; Brunetti P; Bolli GB
    Diabetologia; 1993 Nov; 36(11):1191-7. PubMed ID: 8270135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
    Attia N; Jones TW; Holcombe J; Tamborlane WV
    Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-induced hypoglycaemia in IDDM patients treated with a short-acting insulin analogue.
    Tuominen JA; Karonen SL; Melamies L; Bolli G; Koivisto VA
    Diabetologia; 1995 Jan; 38(1):106-11. PubMed ID: 7744214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
    Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of lispro-insulin in hemodialysis patients with diabetes mellitus.
    Czock D; Aisenpreis U; Rasche FM; Jehle PM
    Int J Clin Pharmacol Ther; 2003 Oct; 41(10):492-7. PubMed ID: 14703957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
    De Feo P; Bolli G; Perriello G; De Cosmo S; Compagnucci P; Angeletti G; Santeusanio F; Gerich JE; Motolese M; Brunetti P
    Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.